CEACAM5 and neoplasm: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are frequently used tumor markers in CRC follow-up, and while these might not have the same efficacy in monitoring recurrence [25], they might be useful in certain subgroups of CRC patients [26, 27].